ERGOLINE AND TRYPTAMINE-BASED COMPOUNDS, AND USES OF THE SAME
This invention relates to pharmaceutically acceptable ergoline and tryptamine-based compounds (e.g. analogues, prodrugs and salts thereof). In particular, though not exclusively, the invention relates to formulations and uses of the same as a medicament, alone or in combination with additional pharm...
Saved in:
Main Authors | , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
18.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This invention relates to pharmaceutically acceptable ergoline and tryptamine-based compounds (e.g. analogues, prodrugs and salts thereof). In particular, though not exclusively, the invention relates to formulations and uses of the same as a medicament, alone or in combination with additional pharmaceutically acceptable compounds.
La présente invention concerne des composés à base d'ergoline et de tryptamine pharmaceutiquement acceptables (par exemple des analogues, des promédicaments et des sels de ceux-ci). En particulier, bien que non exclusivement, l'invention concerne des formulations et leurs utilisations en tant que médicament, seuls ou en association avec des composés pharmaceutiquement acceptables supplémentaires. |
---|---|
Bibliography: | Application Number: WO2023GB51872 |